Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
The company describes retatrutide as an investigational once-weekly triple-hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors with a single molecule.[4] This development history is important because retatrutide was designed as a next-generation incretin therapy rather than as a simple modification of an existing GLP-1 agent
Frequently asked questions What is the CJC-1295 + Ipamorelin Blend
If your workouts feel harder than expected or you feel drained after physical activity, metabolic support may be worth discussing
IV therapy delivers NAD+ directly into your bloodstream, bypassing the digestive system for 100% bioavailability
Product ID: 9158007
US$ 24.71
US$ 24.66
US$ 29.38
US$ 23.78
US$ 22.73
